Highlights: Twice-yearly injectable option approved for asthma and chronic rhinosinusitis with nasal polyps T
Vous n'êtes pas connecté
Maroc - MEDINDIA.NET - Medindia Health News - 12/Jan 14:57
A new add-on therapy administered every six months targets key inflammatory pathways in asthma and chronic rhinosinusitis patients.
Highlights: Twice-yearly injectable option approved for asthma and chronic rhinosinusitis with nasal polyps T
Highlights: Twice-yearly injectable option approved for asthma and chronic rhinosinusitis with nasal polyps T
A new study has found that online therapy can help adults with asthma feel less anxious and improve their daily lives. The treatment is called...
A new study has found that online therapy can help adults with asthma feel less anxious and improve their daily lives. The treatment is called...
Anktiva, also known as nogapendekin alfa inbakicept, is a new cancer therapy that boosts the immune system to target cancer cells. The Saudi Food and...
A blood metabolomics test predicts asthma attacks up to 5 years ahead by measuring inflammatory lipid and steroid ratios tied to disease...
The Ondo State Government has declared its readiness to shut down any private primary or secondary school that obstructs health workers in the conduct...
When people in Trinidad and Tobago think about migration, the same destinations usually dominate the conversation: the United States, Canada, and the...
When people in Trinidad and Tobago think about migration, the same destinations usually dominate the conversation: the United States, Canada, and the...
Launched in 2018, NPY scheme provides ₹1,000 per month to notified TB patients to support a nutrient-rich diet, which plays a crucial role in...